beta
EBIO
Eleven Biotherapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Eleven Biotherapeutics Inc is a biotechnology-based firm in the United States. It is engaged in the development of therapeutics to cure diseases related to the eye.
Market Cap: 29.3 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.elevenbio.com
Shares Outstanding: 31.8 Million
Float: 30.8 Million
Dividend: 0.0 (0.0%)
Beta: 3.009839
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1099 trading days
From: 2014-02-27 To: 2018-05-16
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|